Sweden - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics

Since 2014, Sweden Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics was up 62.7% year on year. In 2019, the country was number 14 among other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics at €641,811,971.12. Sweden is overtaken by Greece, which was ranked number 13 at €870,508,456.38 and is followed by Finland at €595,029,299.45. Germany topped the ranking with €16,376,860,638.2 in 2019, a growth of 0.5% compared to 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden recorded the best 5 years average growth at +62.7% per year, while Montenegro witnessed the worst performance at -6.3% per year.

Loading...

Date Euros
2019 641,811,971.12
2018 57,420,918.00
2017 2,600,013,492.00
2016 45,896,039.00
2015 57,565,296.00
Download all data from 1996 to 2019

How does Sweden rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?

# 29 Countries Euros Last YoY 5‑years CAGR
1 #1
Germany
16,376,860,638.20 2019 +0.5 % +3.5 % View data
2 #2
Ireland
14,139,386,320.45 2019 +21.9 % -5.8 % View data
13 #13
Greece
870,508,456.38 2019 +1.0 % +0.7 % View data
14 #14
Sweden
641,811,971.12 2019 +1,017.7 % +62.7 % View data
15 #15
Finland
595,029,299.45 2019 +3.0 % -0.1 % View data
Compare all 29 countries

Go Top